{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:47:19Z","timestamp":1782578839646,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.humpath.2015.08.020","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T01:25:05Z","timestamp":1443230705000},"page":"104-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions"],"prefix":"10.1016","volume":"47","author":[{"given":"Ben","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene Tuft","family":"Stavnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Hellesylt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pio","family":"Zeppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pinamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremias","family":"Wohlschlaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2015.08.020_bb0005","series-title":"Serous effusions","year":"2011"},{"key":"10.1016\/j.humpath.2015.08.020_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.humpath.2015.08.020_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/153537020623100103","article-title":"Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis","volume":"231","author":"Ii","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.humpath.2015.08.020_bb0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cytogfr.2003.12.001","article-title":"Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?","volume":"15","author":"Wielockx","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.humpath.2015.08.020_bb0025","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1158\/1078-0432.CCR-06-1059","article-title":"Gene expression signatures differentiate ovarian\/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma","volume":"12","author":"Davidson","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2015.08.020_bb0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1582-4934.2010.01019.x","article-title":"Gene expression signatures differentiate ovarian\/peritoneal serous carcinoma from breast carcinoma in effusions","volume":"15","author":"Davidson","year":"2011","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.humpath.2015.08.020_bb0035","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.humpath.2011.06.015","article-title":"Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions","volume":"43","author":"Davidson","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2015.08.020_bb0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7314\/APJCP.2012.13.2.505","article-title":"Application of MMP-7 and MMP-10 in assisting the diagnosis of malignant pleural effusion","volume":"13","author":"Cheng","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.humpath.2015.08.020_bb0045","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/dc.20771","article-title":"MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells","volume":"35","author":"Davidson","year":"2007","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2015.08.020_bb0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00428-007-0448-x","article-title":"Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions","volume":"451","author":"Facchetti","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2015.08.020_bb0055","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1007\/s13277-013-1458-8","article-title":"Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.humpath.2015.08.020_bb0060","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1158\/1078-0432.CCR-05-1473","article-title":"Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells","volume":"12","author":"Lloyd","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2015.08.020_bb0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/1078-0432.CCR-06-0691","article-title":"An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma","volume":"13","author":"Meinhold-Heerlein","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2015.08.020_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2011.11.050","article-title":"Evaluation of ovarian cancer remission markers HE4, MMP7 and mesothelin by comparison to the established marker CA125","volume":"125","author":"Schummer","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2015.08.020_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/1940-6207.CAPR-14-0248","article-title":"A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care","volume":"8","author":"Shadfan","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.humpath.2015.08.020_bb0080","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3892\/or.2011.1608","article-title":"Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer","volume":"27","author":"Brun","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2015.08.020_bb0085","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/ijc.22067","article-title":"Prognostic significance of matrix metalloproteinase-7 in epithelial ovarian cancer and its relation to beta-catenin expression","volume":"119","author":"Sillanp\u00e4\u00e4","year":"2006","journal-title":"Int J Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715003470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715003470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T20:44:33Z","timestamp":1567197873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817715003470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0046817715003470"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2015.08.020","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2015.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}